Combined enzyme defect of mitochondrial fatty acid oxidation

J Clin Invest. 1992 Oct;90(4):1219-25. doi: 10.1172/JCI115983.

Abstract

A young girl presented with recurrent episodes of muscle weakness culminating in a severe attack of generalized muscle weakness. In the muscle mitochondria from the patient there was an abnormal pattern of intermediates of beta-oxidation with an accumulation of 3-hydroxyacyl- and 2-enoyl-CoA and carnitine esters, and 3-oxoacylcarnitines. There was low activity of long-chain 3-hydroxyacyl-CoA dehydrogenase in mitochondria from all tissues. The activity of long-chain 2-enoyl-CoA hydratase was low in muscle mitochondria and 3-oxoacyl-CoA thiolase activity measured with 3-oxohexadecanoyl-CoA as substrate was low in fibroblast, muscle, and cardiac mitochondria but only partial deficiency was present when the activity was measured with 3-oxooctanoyl-CoA. The activity of the long-chain 3-hydroxyacyl-CoA dehydrogenase and long-chain 3-oxoacyl-CoA thiolase in fibroblasts from the patient's parents was intermediate between those of controls and the patient. The patient has a combined defect of the long-chain 3-hydroxyacyl-CoA dehydrogenase, long-chain 3-oxoacyl-CoA thiolase, and long-chain 2-enoyl-CoA hydratase which appears to be inherited in an autosomal recessive manner. This suggests there is a multifunctional enzyme catalyzing these activities in human mitochondria and that this enzyme is deficient in our patient.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3-Hydroxyacyl CoA Dehydrogenases / deficiency*
  • Adult
  • Child, Preschool
  • Enoyl-CoA Hydratase / deficiency*
  • Fatty Acids / metabolism*
  • Female
  • Humans
  • Lipid Metabolism, Inborn Errors / enzymology
  • Male
  • Mitochondria / enzymology*
  • Muscular Diseases / etiology
  • Oxidation-Reduction

Substances

  • Fatty Acids
  • 3-Hydroxyacyl CoA Dehydrogenases
  • Enoyl-CoA Hydratase